CLFD
Clearfield, Inc.
CLFD's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over CLFD overall, supported by stronger valuation and stronger fundamentals.
CLFD Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Stable | |
| Healthy |
CLFD's balance sheet is currently healthy, and its cash flow is stable, but its revenue and profitability are under pressure.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CLFD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 13x | N/A | N/A |
| Forward | 35x | $31.27 | — |
| Fair | 37x | N/A | N/A |
| Expensive | 46x | N/A | N/A |
| Current | 223x | $31.27 | — |
Historical ranges are pointers, not guarantees.
CLFD's PE is 223x, but its earnings don't support one, so it isn't a reliable read right now.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
CLFD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
CLFD has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CLFD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.89 | — |
| Q2 2026 | -$0.51 | -5200% |
| Q1 2026 | -$0.62 | -$0.48 |
| Q4 2025 | -$0.49 | +$0.14 |
| Q3 2025 | -$0.58 | +$0.27 |
| Q2 2025 | $0.01 | +$0.63 |
| Q1 2025 | -$0.14 | +$0.11 |
| Q4 2024 | -$0.63 | -177% |
| Q3 2024 | -$0.85 | -139% |
CLFD has swung to a loss: it lost $0.51 per share over the past year, after a profit the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over CLFD on earnings quality, reporting a profit while its opponent remains loss making.
CLFD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $43.9M | -12% |
| Q1 2026 | $34.4M | -27% |
| Q4 2025 | $34.3M | -3.2% |
| Q3 2025 | $17.6M | -62% |
| Q2 2025 | $49.9M | +2.3% |
| Q1 2025 | $47.2M | +28% |
| Q4 2024 | $35.5M | +3.6% |
| Q3 2024 | $46.8M | -5.9% |
CLFD's revenue has slid since its 2022 peak: $44M last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 5.9% | +2.9 points |
| Q1 2026 | -6% | -6.6 points |
| Q4 2025 | -5.3% | +5.9 points |
| Q3 2025 | 25% | +31 points |
| Q2 2025 | 3% | +7.7 points |
| Q1 2025 | 0.6% | +27 points |
| Q4 2024 | -11% | +13 points |
| Q3 2024 | -6.4% | -9.9 points |
CLFD's operating margin was 5.9% last quarter, up 2.9 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over CLFD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over CLFD on profitability, with a higher operating margin.
CLFD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $8.9M | +19% |
| Q1 2026 | -$2.1M | -420% |
| Q4 2025 | -$2.4M | -148% |
| Q3 2025 | $8.9M | -9% |
| Q2 2025 | $7.5M | +184% |
| Q1 2025 | $654K | +$5.9M |
| Q4 2024 | $5.1M | -7.2% |
| Q3 2024 | $9.8M | +82% |
CLFD still generates free cash flow, though less than at its 2024 peak: $13M over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over CLFD on cash flow, with more consistent year-over-year improvement.
CLFD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -78.4K shares |
| 1 year | -1.7% | -242K shares |
| 3 years | -11% | -1.7M shares |
| 5 years | -1.6% | -220K shares |
| Available history | +1% | +141K shares |
CLFD has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $897,000 |
| Q1 2026 | $7.3M |
| Q4 2025 | $5.3M |
| Q3 2025 | $12,000 |
| Q2 2025 | $5.7M |
| Q1 2025 | $4.7M |
| Q4 2024 | $6.3M |
| Q3 2024 | — |
CLFD spent $14M buying back its own shares over the past year, down 19% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CLFD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -2.5x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.7x | Net Cash |
| Q2 2025 | -13.5x | Net Cash |
| Q4 2023 | -1.8x | Net Cash |
| Q3 2023 | -0.8x | Net Cash |
| Q2 2023 | -0.5x | Net Cash |
CLFD has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CLFD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.5 | Neutral |
| Stochastic | 55.1 | Neutral |
CLFD's weekly RSI is 50 (neutral) and its Stochastic is 55 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CLFD PE vs Technology Sector
| Metric | CLFD | Sector median | Relative |
|---|---|---|---|
| PE | 223x | 28x | 702% above |
| PE % | 94 | 35 | 59 pts above |
CLFD is trading at 223x earnings, a 702% premium to the Technology sector's median of 28x, though its earnings don't support one.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over CLFD on valuation relative to its sector.
CLFD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.0 | 1% above |
| 20 week MA | $30.5 | 2.6% above |
| 50 week MA | $31.9 | 2% below |
| 100 week MA | $33.1 | 5.6% below |
| 200 week MA | $35.4 | 12% below |
CLFD has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
CLFD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.9 | $24.8 | +78% |
| 2021 | $24.8 | $78.5 | +217% |
| 2022 | $78.5 | $95.5 | +22% |
| 2023 | $95.5 | $29.1 | -70% |
| 2024 | $29.1 | $31.1 | +7% |
| 2025 | $31.1 | $30.2 | -3.1% |
| 2026 YTD | $30.2 | $31.3 | +3.6% |
CLFD has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.